Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | IMTX Immatics N.V. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $8.37 +0.5% | $14.86 -2.5% |
| StockIQ Score | 28F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 11F | 13F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 68B- | 50C- |
| Quality | — | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Immatics (IMTX) outperforms Ascentage Pharma (AAPG) in investor and technical scores, with 61 versus 37 and 64 versus 18 respectively. Its "MODERATE" rating also suggests stronger overall stability than AAPG’s "WEAK" rating. However, AAPG has higher growth and valuation scores, though these are not provided for IMTX.
